【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
Medigen Biotechnology (6794) reported April 2026 revenue of 18.94 million yuan, a significant decrease of 65.5% year-on-year. This indicates a challenging period for the company in the biotech and medical sector.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 09:44 (1h 44m after Collected)
## Press Release Information
Title: 【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
Company Name: Medigen Biotechnology
Industry: Biotechnology and Medical Industry
Data Month: 2026-04
Monthly Revenue: 1,894 thousand yuan (0.02 billion)
Year-on-Year Change: -65.5%
Keywords: Monthly Revenue, Biotechnology and Medical Industry
Title: 【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
Company Name: Medigen Biotechnology
Industry: Biotechnology and Medical Industry
Data Month: 2026-04
Monthly Revenue: 1,894 thousand yuan (0.02 billion)
Year-on-Year Change: -65.5%
Keywords: Monthly Revenue, Biotechnology and Medical Industry